What Do We Know About the Johnson & Johnson Vaccine?

Initial data about the efficacy of the single shot Johnson & Johnson vaccine – which was developed at Beth Israel Deaconess Medical Center in collaboration with Johnson & Johnson – has the Barouch Lab and Center for Virology and Vaccine Research at BIDMC feeling optimistic about making more vaccine options available to the public. The Johnson & Johnson vaccine has been proven to offer strong protection against the Brazil and South African variants, as well. All of this has also led the company to apply for Emergency Use Authorization through the FDA.

COVID Conversations welcomes Jessica Ansel, Nurse Practitioner/Clinical Research Coordinator at the Center for Virology and Vaccine Research back to answer the question “What do we know about the Johnson & Johnson Vaccine?”

Watch All COVID Conversations